Library · Neoplasm

Ductal carcinoma in situ

Make it clearer

Ductal carcinoma in situ is a breast cancer, and what defines it is where it still is. The abnormal cells remain sealed inside the duct, never having crossed the basement membrane, the thin wall that separates the tube from the surrounding tissue. That is why it is called noninvasive: the cells are inside the tube, and the tube's wall is intact.

What sits inside is a clonal proliferation in the epithelium lining the ducts and lobules, meaning cells that all descend from a single cell that went out of control. What keeps them shut in is the basement membrane built by the myoepithelial cells, the layer that wraps around the outside of the duct.

That boundary decides the name of the disease. If the basement membrane is breached, it is no longer called in situ: it becomes invasive breast cancer.

And this is how it usually turns up. Nine out of ten cases of ductal carcinoma in situ are found on a screening mammogram, the one done when there are no symptoms at all. But mammography alone does not settle the diagnosis: a tissue biopsy is needed.

In brief

Ductal carcinoma in situ is a noninvasive breast cancer: the abnormal cells remain confined within the basement membrane.

The cells are still inside the tube, and the tube's wall is still intact.

It is a clonal proliferation of ductal-lobular epithelium, held in by the myoepithelial basement membrane.

If that basement membrane is breached, the diagnosis is no longer in situ but invasive breast cancer.

Nine out of ten are found on screening mammography, but diagnosis requires a biopsy.

Sources (1)
  1. National Center for Biotechnology Information, StatPearls PublishingBreast Ductal Carcinoma in Situ, StatPearlsPublished

This page explains the topic in general terms; it does not tell anyone what treatment to follow.

Updated

Know someone who would find this helpful?

Share it with them.